Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 12:39 AM
NCT ID:
NCT03284567
Eligibility Criteria:
Inclusion Criteria:
* Women surgically managed for breast cancer, local and regional advanced breast cancer.
* Completion of adjuvant chemotherapy and radiation therapy.
* Legally competent persons with ability to read and understand Danish.
* Signed informed consent.
* Performance level 0-1 (WHO).
Exclusion Criteria:
* WHO performance level \> 1.
* Osteoporosis (T-score \< -2.5).
* Known metastatic breast cancer (stage IV).
* Women in DBCG-group I (age =\> 60 years, tumor =\< 10 mm, invasive ductal carcinoma grade I, invasive lobular carcinoma grade I / II, estrogen receptor positive and HER2 normal).
* Cardiovascular or pulmonary disorders (e.g., arrhythmias, ischemic heart disease, unregulated high blood pressure, chronic obstructive lung disease).
* Ongoing anticoagulant therapy (vitamin K antagonists; Marevan, Marcoumar and low molecular weight heparins; Innohep, Clexane, Fragmin) for pulmonary embolism or deep venous thrombosis (DVT) due to increased bleeding risk of falls and clashes with other players during exercise.
* Current or scheduled chemotherapy and radiation therapy in the intervention period (12 months).
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03284567
Study Brief:
Protocol Section:
NCT03284567